Ultragenyx PharmaceuticalRARE 
$59.613.31%24h
3.31%24h
Global rank2819
Market cap$4.89B
Change 7d6.94%
YTD Performance25.92%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Ultragenyx Pharmaceutical (RARE)
As of November 2024, Ultragenyx Pharmaceutical has a market cap of $4.89B. This makes Ultragenyx Pharmaceutical the world's 2819th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Ultragenyx Pharmaceutical from 2014 to 2024
-
Value:-
Market cap history of Ultragenyx Pharmaceutical from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $3.78B | -3.62% |
| 2023 | $3.93B | 3.22% |
| 2022 | $3.80B | -44.90% |
| 2021 | $6.90B | -39.25% |
| 2020 | $11.37B | 224.12% |
| 2019 | $3.51B | -1.77% |
| 2018 | $3.57B | -6.25% |
| 2017 | $3.81B | -34.03% |
| 2016 | $5.77B | -37.32% |
| 2015 | $9.21B | 155.65% |
| 2014 | $3.60B | - |
RARE Market Cap Today is $4.89B 3.31% - 16 Nov 2024
View largest stocks by market cap 
